kotak-logo
JHS Svendgaard Laboratories Ltd's revenue decreased 30.6% YoY
  • 28 May 2025
  • JHS Svendgaard Laboratories Ltd reported a 0.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 30.6%.
  • Its expenses for the quarter were down by 6.7% QoQ and 26.1% YoY.
  • The net profit decreased 59.2% QoQ and decreased 92.6% YoY.
  • The earnings per share (EPS) of JHS Svendgaard Laboratories Ltd declined at 0.1 during Q4FY25.

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

JHS Svendgaard Laboratories Ltd is a company engaged in the manufacturing and distribution of oral care products. As a key player in the oral hygiene sector, the company focuses on products such as toothbrushes, toothpastes, and mouthwashes. The company serves both domestic and international markets, providing private label manufacturing services and catering to various retail brands. Recent developments concerning JHS Svendgaard Laboratories Ltd have not been provided, and thus specific updates or strategic changes in its operations remain unspecified.

During the fourth quarter of the fiscal year 2025 (Q4FY25), JHS Svendgaard Laboratories Ltd reported a total income of ₹23.04 crores. This represents a quarter-over-quarter (QoQ) increase of 0.5% from the previous quarter (Q3FY25), where the total income was ₹22.93 crores. However, on a year-over-year (YoY) basis, there is a noticeable decline of 30.6% compared to Q4FY24, when the total income stood at ₹33.21 crores. These figures highlight the company's revenue performance over the specified periods.

For Q4FY25, the company recorded a profit before tax of ₹0.18 crores, which marks a significant improvement from a loss of ₹1.58 crores in Q3FY25. Compared to Q4FY24, when the company had a loss before tax of ₹16.37 crores, this represents a notable positive change. Tax expenses for Q4FY25 were ₹0.93 crores, indicating a substantial increase from ₹0.25 crores in Q3FY25, and a reversal from a tax credit of ₹6.24 crores in Q4FY24. Profit after tax for Q4FY25 was a loss of ₹0.75 crores, which is a reduction in losses both QoQ, from ₹1.84 crores, and YoY, from ₹10.12 crores. The earnings per share (EPS) also improved to a loss of ₹0.10 from a loss of ₹0.20 in the previous quarter and a loss of ₹1.50 in the same quarter last year.

The total expenses for Q4FY25 were reported at ₹22.86 crores, showing a decrease of 6.7% from Q3FY25's expenses of ₹24.51 crores. This also represents a decline of 26.1% compared to the expenses in Q4FY24, which were ₹30.95 crores. The reduction in expenses over both the QoQ and YoY periods is a key operational metric. Despite the overall loss, the management of expenses has been a critical factor in the improvement of the company's profitability metrics, as seen in the reduced net loss figures for the quarter.

JHS Svendgaard Laboratories Ltd announced its Q1 FY 2025-26 results on 14 August, 2025.

JHS Svendgaard Laboratories Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.

Key highlights of JHS Svendgaard Laboratories Ltd Q1 FY 2025-26 results include:

  • Revenue: ₹24.45 crore
  • Net Profit: ₹1.06 crore
  • EBITDA: ₹2.66 crore
  • Year-over-Year Growth: -1.4%
  • Quarter-over-Quarter Growth: 6.1%

JHS Svendgaard Laboratories Ltd reported a net loss of ₹1.06 crore in Q1 FY 2025-26, reflecting a -268.3% year-over-year growth.

JHS Svendgaard Laboratories Ltd posted a revenue of ₹24.45 crore in Q1 FY 2025-26.